Harvest One Provides An Update On Dream Water® On The Occasion of World Sleep Day 2019 Cannabis Investing News
Axovant Sciences Announces Pricing of $40 Million Public Offering of Common Shares Genetics Investing
Cannara Biotech Announces Expansion of Phase 1 Build-Out and Board of Directors Update Cannabis Investing News
NervGen Pharma Completes $10 Million Initial Public Offering; Shares to Commence Trading on TSX-V on March 15, 2019 – Symbol “NGEN” Pharmaceutical Investing
Checkpoint Therapeutics Announces Issuance of Two New Patents for EGFR Inhibitor CK-101 Biotech Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
